Kath Nolan's Publications

Listed with most recent publications first

2010
Cobbold SP, Adams E, Nolan KF, Regateiro FS, Waldmann H.
Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link.
Immunol Rev. 2010 Jul;236:203-18. PubMed PMID: 20636819.
2010
Farquhar CA, Paterson AM, Cobbold SP, Garcia Rueda H, Fairchild PJ, Yates SF, Adams E, Saunders NJ, Waldmann H, Nolan KF.
Tolerogenicity is not an absolute property of a dendritic cell.
Eur J Immunol. 2010 Jun;40(6):1728-37. PubMed PMID: 20373289.
Howie, D., Nolan, KF., Daley, S., Butterfield, E., Adams, E., Garcia-Rueda, H., Thompson, C., Saunders, NJ., Cobbold, SP., Tone, Y., Tone, M., Waldmann, H.
2009
MS4A4B is a GITR-associated membrane adapter expressed by regulatory T cells which modulates T cell activation.
J.Immunol, in press (2009)
Poulton, LD, Nolan, KF*, Anastasaki, C, Waldmann, H & Patton, EE. [*joint first author]
2009
A novel role for GITRL in early embryonic zebrafish development.
Int J Dev Biol. 2009 Jul 1. [Epub ahead of print] PubMed PMID:19598108.
Cobbold, SP, Adams, E, Farquhar, CA, Nolan, KF, Howie, D, Lui, KO, Fairchild, PJ, Mellor, AL, Ron, D & Waldmann, H.
2009
Infectious tolerance via the consumption of essential amino acids and mTOR signalling.
Proc Natl Acad Sci U S A. Epub 2009 June 30. doi:10.1073/pnas.0903919106.
Link to full version of the paper (Open Access).
Nolan KF, Cobbold SP, Waldmann H.
2007
SAGE analysis of cell types involved in tolerance induction.
Methods Mol Biol. 2007;380:225-51.
Fairchild PJ, Nolan KF, Waldmann H.
2007
Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells.
Methods Mol Biol. 2007;380:59-72.
Yates SF, Paterson AM, Nolan KF, Cobbold SP, Saunders NJ, Waldmann H, Fairchild PJ.
2007
Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.
J Immunol. 2007 Jul 15;179(2):967-76.
Fairchild PJ, Robertson NJ, Cartland S, Nolan KF, Waldmann H.
2005
Cell replacement therapy and the evasion of destructive immunity.
Stem Cell Rev. 2005;1(2):159-67. Review.
Cobbold SP, Adams E, Graca L, Daley S, Yates S, Paterson A, Robertson NJ, Nolan KF, Fairchild PJ, Waldmann H.
2006
Immune privilege induced by regulatory T cells in transplantation tolerance.
Immunol Rev. 2006 Oct;213:239-55. Review.
Paterson AM, Yates SF, Nolan KF, Waldmann H.
2005
The new immunosuppression: intervention at the dendritic cell-T-cell interface.
Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):397-411. Review.
Fairchild PJ, Nolan KF, Cartland S, Waldmann H.
2005
Embryonic stem cells: a novel source of dendritic cells for clinical applications.
Int Immunopharmacol. 2005 Jan;5(1):13-21.
Fairchild PJ, Cartland S, Nolan KF, Waldmann H.
2004
Embryonic stem cells and the challenge of transplantation tolerance.
Trends Immunol. 2004 Sep;25(9):465-70. Review.
Nolan KF, Strong V, Soler D, Fairchild PJ, Cobbold SP, Croxton R, Gonzalo JA, Rubio A, Wells M, Waldmann H.
IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals.
J Immunol. 2004 Feb 15;172(4):2201-9.
Fairchild PJ, Nolan KF, Waldmann H.
Probing dendritic cell function by guiding the differentiation of embryonic stem cells.
Methods Enzymol. 2003;365:169-86.
Cobbold SP, Nolan KF, Graca L, Castejon R, Le Moine A, Frewin M, Humm S, Adams E, Thompson S, Zelenika D, Paterson A, Yates S, Fairchild PJ, Waldmann H.
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms.
Immunol Rev. 2003 Dec;196:109-24.
Fairchild PJ, Nolan KF, Cartland S, Graca L, Waldmann H.
Stable lines of genetically modified dendritic cells from mouse embryonic stem cells.
Transplantation. 2003 Aug 15;76(3):606-8.
Fairchild, PJ., Brook, RL., Gardner, L., Graca, L., Strong, V., Tone, Y., Tone, M., Nolan, KF., Waldmann, H.
Directed differentiation of dendritic cells from mouse embryonic stem cells: a novel tool for identifying targets for immunotherapy.
in Dodet, B., and Vicari, M. (Eds)
Pluripotent stem cells: therapeutic perspectives and ethical issues. pp 25-38.
John Libbey Eurotext, Paris (Pub) (2001)
Yun CO, Nolan KF, Beecham EJ, Reisfeld RA, Junghans RP.
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
Neoplasia. 2000 Sep-Oct;2(5):449-59.
Fairchild PJ, Brook FA, Gardner RL, Graca L, Strong V, Tone Y, Tone M, Nolan KF, Waldmann H.
Directed differentiation of dendritic cells from mouse embryonic stem cells.
Curr Biol. 2000 Nov 30;10(23):1515-8.
Nolan KF, Yun CO, Akamatsu Y, Murphy JC, Leung SO, Beecham EJ, Junghans RP.
Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
Clin Cancer Res. 1999 Dec;5(12):3928-41.
Tone M, Nolan KF, Walsh LA, Tone Y, Thompson SA, Waldmann H.
Structure and chromosomal location of mouse and human CD52 genes.
Biochim Biophys Acta. 1999 Sep 3;1446(3):334-40.
Akamatsu Y, Murphy JC, Nolan KF, Thomas P, Kreitman RJ, Leung SO, Junghans RP.
A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.
Clin Cancer Res. 1998 Nov;4(11):2825-32.
Nolan KF, Greaves DR, Waldmann H.
The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci.
Genomics. 1998 Jul 1;51(1):161-3. No abstract available.
Tone Y, Thompson SA, Babik JM, Nolan KF, Tone M, Raven C, Waldmann H.
Structure and chromosomal location of the mouse interleukin-12 p35 and p40 subunit genes.
Eur J Immunol. 1996 Jun;26(6):1222-7.
Nolan KF, Reid KB.
Properdin.
Methods Enzymol. 1993;223:35-46. No abstract available.
Reid KB, Nolan KF, Lijnen HR, Collen D.
Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. Introduction.
Methods Enzymol. 1993;223:1-9. No abstract available.
Nolan KF, Kaluz S, Higgins JM, Goundis D, Reid KB.
Characterization of the human properdin gene.
Biochem J. 1992 Oct 1;287 ( Pt 1):291-7.
Coleman MP, Murray JC, Willard HF, Nolan KF, Reid KB, Blake DJ, Lindsay S, Bhattacharya SS, Wright A, Davies KE.
Genetic and physical mapping around the properdin P gene.
Genomics. 1991 Dec;11(4):991-6.
Smith KF, Nolan KF, Reid KB, Perkins SJ.
Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat.
Biochemistry. 1991 Aug 13;30(32):8000-8.
Nolan KF, Schwaeble W, Kaluz S, Dierich MP, Reid KB.
Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement.
Eur J Immunol. 1991 Mar;21(3):771-6.
Nolan KF, Reid KB.
Complete primary structure of human properdin: a positive regulator of the alternative pathway of the serum complement system.
Biochem Soc Trans. 1990 Dec;18(6):1161-2.
Nolan KF, Urquidi V, Emery VC, Bishop DH.
The design and use of specific genetic probes to identify closely related bunyaviruses and to determine the genotype of their recombinants.
J Gen Virol. 1989 Aug;70 ( Pt 8):2201-7.

Last updated 2nd September 2010 by Steve Cobbold